|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
258,990,000 |
Market
Cap: |
18.59(B) |
Last
Volume: |
1,033,028 |
Avg
Vol: |
1,895,542 |
52
Week Range: |
$65.11 - $82.04 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 317 |
Guru Rank Value : 4 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
57,902 |
123,113 |
368,767 |
Total Sell Value |
$0 |
$4,317,275 |
$8,902,469 |
$27,563,219 |
Total People Sold |
0 |
4 |
6 |
10 |
Total Sell Transactions |
0 |
5 |
8 |
16 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Macmillan Stephen P |
Chairman, President and CEO |
|
2022-11-11 |
4 |
OE |
$26.21 |
$2,501,011 |
D/D |
95,422 |
2,539,247 |
|
- |
|
Hellmann Elisabeth A |
SVP, Human Resources |
|
2022-11-09 |
4 |
D |
$72.11 |
$13,989 |
D/D |
(194) |
10,479 |
|
- |
|
Mitchell Essex D |
Div. President, GYN Surgical |
|
2022-11-09 |
4 |
D |
$72.11 |
$14,494 |
D/D |
(201) |
9,707 |
|
- |
|
Anderson Erik S |
Div. Pres., Breast & Skeletal |
|
2022-11-09 |
4 |
D |
$72.11 |
$9,446 |
D/D |
(131) |
10,692 |
|
- |
|
Griffin John M. |
General Counsel |
|
2022-11-09 |
4 |
D |
$72.11 |
$43,915 |
D/D |
(609) |
182,085 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2022-11-09 |
4 |
D |
$72.11 |
$15,504 |
D/D |
(215) |
14,529 |
|
- |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2022-11-09 |
4 |
D |
$72.11 |
$49,035 |
D/D |
(680) |
133,008 |
|
- |
|
Verstreken Jan |
Group President, International |
|
2022-11-09 |
4 |
D |
$72.11 |
$9,735 |
D/D |
(135) |
80,663 |
|
- |
|
Thornal Kevin R |
Group Pres, Global Diagnostics |
|
2022-11-09 |
4 |
D |
$72.11 |
$42,617 |
D/D |
(591) |
77,776 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2022-11-09 |
4 |
D |
$72.11 |
$416,507 |
D/D |
(5,776) |
2,486,825 |
|
- |
|
Thornal Kevin R |
Group Pres, Global Diagnostics |
|
2022-11-08 |
4 |
D |
$73.71 |
$52,260 |
D/D |
(709) |
78,367 |
|
- |
|
Anderson Erik S |
Div. Pres., Breast & Skeletal |
|
2022-11-08 |
4 |
D |
$73.71 |
$9,287 |
D/D |
(126) |
10,823 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2022-11-08 |
4 |
D |
$73.71 |
$298,673 |
D/D |
(4,052) |
2,492,601 |
|
- |
|
Griffin John M. |
General Counsel |
|
2022-11-08 |
4 |
D |
$73.71 |
$44,373 |
D/D |
(602) |
182,694 |
|
- |
|
Verstreken Jan |
Group President, International |
|
2022-11-08 |
4 |
D |
$73.71 |
$14,300 |
D/D |
(194) |
80,798 |
|
- |
|
Verstreken Jan |
Group President, International |
|
2022-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,724 |
80,992 |
|
- |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2022-11-08 |
4 |
D |
$73.71 |
$15,258 |
D/D |
(207) |
14,744 |
|
- |
|
Hellmann Elisabeth A |
SVP, Human Resources |
|
2022-11-08 |
4 |
D |
$73.71 |
$17,912 |
D/D |
(243) |
10,673 |
|
- |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2022-11-08 |
4 |
D |
$73.71 |
$50,712 |
D/D |
(688) |
133,688 |
|
- |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2022-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,565 |
134,376 |
|
- |
|
Mitchell Essex D |
Div. President, GYN Surgical |
|
2022-11-08 |
4 |
D |
$73.71 |
$23,735 |
D/D |
(322) |
9,908 |
|
- |
|
Mitchell Essex D |
Div. President, GYN Surgical |
|
2022-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,034 |
10,230 |
|
- |
|
Thornal Kevin R |
Group Pres, Global Diagnostics |
|
2022-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,724 |
79,076 |
|
- |
|
Anderson Erik S |
Div. Pres., Breast & Skeletal |
|
2022-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,362 |
10,949 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2022-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
36,987 |
2,496,653 |
|
- |
|
824 Records found
|
|
Page 5 of 33 |
|
|